Mankind Pharma's Stock Hits All-Time High, Rated as 'Buy' by MarketsMOJO

Mankind Pharma, one of the leading pharmaceutical companies in India, has recently reached an all-time high in its stock price. On September 20, 2024, the company's stock price hit a record high of Rs. 2585, making it a great time for investors to consider buying.

According to MarketsMOJO, a leading stock market analysis and research platform, Mankind Pharma's stock is currently rated as a 'Buy'. This is a positive sign for investors, indicating that the company's stock is expected to perform well in the near future.

In terms of price performance, Mankind Pharma has outperformed the sector by 5.77% and has been on a consecutive gain for the last 2 days, with a 7.75% increase in returns. The stock also touched an intraday high of Rs. 2585, showing a 6.17% increase.

Moreover, Mankind Pharma's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend in the company's stock price and a potential for further growth.

In comparison to the Sensex, Mankind Pharma's stock has shown a strong performance with a 1-year return of 50.58%, while the Sensex has only seen a 24.70% increase. This further highlights the company's strong position in the pharmaceutical industry.

With its consistent growth and positive outlook, Mankind Pharma is a promising investment option for those looking to invest in the pharmaceutical sector. Its recent all-time high in stock price is a testament to the company's success and potential for future growth.